The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity
Abstract
BACKGROUND: The incidence and severity of Clostridium difficile-associated diarrhea (CDAD) has been increasing, and there have been recent reports of metronidazole treatment failure. Metronidazole is still commonly used as first-line treatment for CDAD but has never been compared with vancomycin in a prospective, randomized, double-blind, placebo-controlled trial. We conducted such a trial, stratifying patients according to disease severity, to investigate whether one agent was superior for treating either mild or severe disease. METHODS: From October 1994 through June 2002, patients with CDAD were stratified according to whether they had mild or severe disease based on clinical criteria and were randomly assigned to receive oral metronidazole (250 mg 4 times per day) or oral vancomycin (125 mg 4 times per day) for 10 days. Both groups received an oral placebo in addition to the study drug. Patients were followed up for 21 days to assess cure, treatment failure, relapse, or intolerance. RESULTS: One hundred seventy-two patients were enrolled, and 150 of these patients successfully completed the trial. Among the patients with mild CDAD, treatment with metronidazole or vancomycin resulted in clinical cure in 90% and 98% of the patients, respectively (P=.36). Among the patients with severe CDAD, treatment with metronidazole or vancomycin resulted in clinical cure in 76% and 97% of the patients, respectively (P=.02). Clinical symptoms recurred in 15% of the patients treated with metronidazole and 14% of those treated with vancomycin. CONCLUSIONS: Our findings suggest that metronidazole and vancomycin are equally effective for the treatment of mild CDAD, but vancomycin is superior for treating patients with severe CDAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E., & McDonald, L. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67420-x · Cited by 1,430
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Teasley, D., Olson, M., Gebhard, R., Gerding, D., Peterson, L., Schwartz, M., & Lee, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91036-x · Cited by 785
(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)01892-6 · Cited by 649
Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications
Dallal, R. M., Harbrecht, B. G., Boujoukas, A. J., Sirio, C. A., Farkas, L. M., Lee, K. K., & Simmons, R. L. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00008 · Cited by 628
Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada
Pepin, J., Alary, M.-E., Valiquette, L., Raiche, E., Ruel, J., Fulop, K., Godin, D., & Bourassa, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430315 · Cited by 570
Wenisch, C., Parschalk, B., Hasenhundl, M., Hirschl, A. M., & Graninger, W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.813 · Cited by 505
Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole
Musher, D. M., Aslam, S., Logan, N., Nallacheru, S., Bhaila, I., Borchert, F., & Hamill, R. J. (2005) · Clinical Infectious Diseases · doi:10.1086/430311 · Cited by 504
Fekety, R., McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., & Mulligan, M. E. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.324 · Cited by 376
Recurrent Clostridium Difficile Disease: Epidemiology and Clinical Characteristics
McFarland, L. V., Surawicz, C. M., Rubin, M., Fekety, R., Elmer, G. W., & Greenberg, R. N. (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501553 · Cited by 353
Bolton, R. P., & Culshaw, M. A. (1986) · Gut · doi:10.1136/gut.27.10.1169 · Cited by 320
Bartlett, J. G. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.supplement_4.s265 · Cited by 309
A Cluster of Vancomycin-Resistant Enterococcus faecium in an Intensive Care Unit
Karanfil, L. V., Murphy, M., Josephson, A., Gaynes, R., Mandel, L., Hill, B. C., & Swenson, J. M. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646509 · Cited by 283
Recommendations for Preventing the Spread of Vancomycin Resistance
(1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30140952 · Cited by 281
Reassessment of Clostridium difficile Susceptibility to Metronidazole and Vancomycin
Peláez, T., Alcalá, L., Alonso, R., Rodríguez-Créixems, M., García-Lechuz, J. M., & Bouza, E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1647-1650.2002 · Cited by 259
Pepin, J., Routhier, S., Gagnon, S., & Brazeau, I. (2006) · Clinical Infectious Diseases · doi:10.1086/501126 · Cited by 246
Clostridium difficile-associated disease: new challenges from an established pathogen.
Sunenshine, R. H., & McDonald, L. C. (2006) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.73.2.187 · Cited by 242
Boyle, J. F., Soumakis, S. A., Rendo, A., Herrington, J. A., Gianarkis, D. G., Thurberg, B. E., & Painter, B. G. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.5.1280-1285.1993 · Cited by 217
Secular Trends in Hospital‐Acquired Clostridium difficile Disease in the United States, 1987–2001
Archibald, L. K., Banerjee, S. N., & Jarvis, W. R. (2004) · The Journal of Infectious Diseases · doi:10.1086/383045 · Cited by 206
Diarrhea Etiology in a Children’s Hospital Emergency Department: A Prospective Cohort Study
Klein, E. J., Boster, D. R., Stapp, J. R., Wells, J. G., Qin, X., Clausen, C. R., Swerdlow, D. L., Braden, C. R., & Tarr, P. I. (2006) · Clinical Infectious Diseases · doi:10.1086/507335 · Cited by 193
McEllistrem, M. C., Carman, R. J., Gerding, D. N., Genheimer, C. W., & Zheng, L. (2005) · Clinical Infectious Diseases · doi:10.1086/427113 · Cited by 173
Barbut, F. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440120107012 · Cited by 170
Carmeli, Y., Eliopoulos, G. M., & Samore, M. H. (2002) · Emerging infectious diseases · doi:10.3201/eid0808.010418 · Cited by 158
Factors associated with prolonged symptoms and severe disease due to Clostridium difficile
Kyne, L., Merry, C., O'Connell, B., Kelly, A., Keane, C., & O'Neill, D. (1999) · Age and Ageing · doi:10.1093/ageing/28.2.107 · Cited by 154
The NewClostridium difficile— What Does It Mean?
Bartlett, J. G., & Perl, T. M. (2005) · New England Journal of Medicine · doi:10.1056/nejme058221 · Cited by 153
Update on the changing epidemiology of Clostridium difficile-associated disease
McFarland, L. V. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1029 · Cited by 149
Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea.
Anand, A., Bashey, B., Mir, T., & Glatt, A. E. (1994) · PubMed · Cited by 138
Nair, S. P., Yadav, D. K., Corpuz, M. O., & Pitchumoni, C. S. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00541.x · Cited by 130
Factors Associated With Failure of Metronidazole in Clostridium difficile–associated Disease
Fernandez, A. A., Anand, G., & Friedenberg, F. K. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200405000-00005 · Cited by 111
Risk Factors for Early RecurrentClostridium difficile–Associated Diarrhea
Do, A. N., Fridkin, S. K., Yechouron, A., Banerjee, S. N., Killgore, G., Bourgault, A., Jolivet, M., & Jarvis, W. R. (1998) · Clinical Infectious Diseases · doi:10.1086/513952 · Cited by 82
Cited by
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Metadata
- Authors
- Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-08-01
- Volume
- 45
- Issue
- 3
- Pages
- 302-307
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2147511770
- Cited by
- 1,252
- References
- 35
- FWCI
- 41.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.